Protocols
8 protocol(s) meet the specified criteria
Disease Site: Multiple Myeloma
Protocol No.TitleStatus
10-CBAA multicenter access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) for transplantation in pediatric and adult patients with hematologic malignancies and other indicationsOpen
A061202A Phase I/II Study of Pomalidomide, Dexamethasone and Ixazomib vs. Pomalidomide and Dexamethasone for Patients with Multiple Myeloma Relapsing on Lenalidomide as part of first line therapy.Open
ACCL1131A Phase III Open-Label Trial of Caspofungin vs. Azole Prophylaxis for Patients at High-Risk for Invasive Fungal Infections (IFI) Following Allogeneic Hematopoietic Cell Transplantation (HCT)Open
FADOI03-2016Apixaban for the Treatment of Venous Thromboembolism in Patients with Cancer: a Prospective Randomized Open Blinded End-Point (PROBE) Study - The Caravaggio StudyOpen
KCP-330-017STOMPKCP-330-017 STOMP A Phase 1b/2 Study of Selinexor (KPT-330) in Combination with Backbone Treatments for Relapsed/Refractory Multiple MyelomaOpen
LCCC1603-ATLPhase I Study of the Administration of Autologous CAR-T Cells Targeting the CD138 Antigen for Relapsed / Refractory Multiple MyelomaOpen
NP39403NP39403-Open label, Multicenter, Dose escalation/expansion phase 1b study to evaluate safety, pharmacokinetics and activity of BET inhibitor R06870810, given as mono and combination therapy to patients with advanced Multiple MyelomaOpen
S1702-CIRBS1702, CIRB " A Phase II Study of Isatuximab (SAR650984) (NSC-795145) for patients with previously treated Al AmyloidosisOpen